Compared to SJS/TEN, which presents acutely, SJS/TEN-like eruptions often develop over the course of weeks to months or late in the course of treatment ranging up to 420 days following PD-1/PD-L1 therapy initiation. This evidence concerns the gene CD274 and toxic epidermal necrolysis.